Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants LJ Abu-Raddad, H Chemaitelly, AA Butt New England Journal of Medicine 385 (2), 187-189, 2021 | 1096 | 2021 |
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021 | 872 | 2021 |
Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 469 | 2022 |
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021 | 456 | 2021 |
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ... Viruses 11 (8), 762, 2019 | 445 | 2019 |
Potential adverse effects of resveratrol: A literature review A Shaito, AM Posadino, N Younes, H Hasan, S Halabi, D Alhababi, ... International journal of molecular sciences 21 (6), 2084, 2020 | 444 | 2020 |
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2 N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ... Viruses 12 (6), 582, 2020 | 427 | 2020 |
Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 415 | 2022 |
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ... Nature medicine 27 (9), 1614-1621, 2021 | 403 | 2021 |
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 371 | 2022 |
Epstein–Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update MK Smatti, DW Al-Sadeq, NH Ali, G Pintus, H Abou-Saleh, GK Nasrallah Frontiers in oncology 8, 211, 2018 | 344 | 2018 |
Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety A Shaito, DTB Thuan, HT Phu, THD Nguyen, H Hasan, S Halabi, ... Frontiers in pharmacology 11, 509974, 2020 | 279 | 2020 |
Synthesis, bioapplications, and toxicity evaluation of chitosan-based nanoparticles BR Rizeq, NN Younes, K Rasool, GK Nasrallah International journal of molecular sciences 20 (22), 5776, 2019 | 233 | 2019 |
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 224 | 2022 |
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis THG Phan, P Paliogiannis, GK Nasrallah, R Giordo, AH Eid, AG Fois, ... Cellular and Molecular Life Sciences 78, 2031-2057, 2021 | 221 | 2021 |
Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms H Slika, H Mansour, N Wehbe, SA Nasser, R Iratni, G Nasrallah, A Shaito, ... Biomedicine & Pharmacotherapy 146, 112442, 2022 | 200 | 2022 |
Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies ME El Zowalaty, AA Al Thani, TJ Webster, AE El Zowalaty, HP Schweizer, ... Future Microbiology 10 (10), 1683-1706, 2015 | 200 | 2015 |
Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa AF Majdalawieh, MW Fayyad, GK Nasrallah Critical reviews in food science and nutrition 57 (18), 3911-3928, 2017 | 196 | 2017 |
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ... EClinicalMedicine 35, 2021 | 191 | 2021 |
Severity of SARS-CoV-2 reinfections as compared with primary infections LJ Abu-Raddad, H Chemaitelly, R Bertollini New England Journal of Medicine 385 (26), 2487-2489, 2021 | 181 | 2021 |